BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 14595338)

  • 41. Human genome project. The honeymoon is over.
    Anderson GC
    Nature; 1990 Jul; 346(6282):309. PubMed ID: 2374602
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of federal programs in the transfer of biomedical technology.
    Phillips SJ
    Artif Organs; 2004 May; 28(5):432-6. PubMed ID: 15113335
    [No Abstract]   [Full Text] [Related]  

  • 43. Pinning down sequencing costs.
    Science; 1990 Dec; 250(4988):1663. PubMed ID: 2270479
    [No Abstract]   [Full Text] [Related]  

  • 44. Sequencing funds 'must remain focused'.
    Wadman M
    Nature; 1998 Jan; 391(6663):114-5. PubMed ID: 9428751
    [No Abstract]   [Full Text] [Related]  

  • 45. Bioinformatics in the human interactome project.
    Ideker T; Valencia A
    Bioinformatics; 2006 Dec; 22(24):2973-4. PubMed ID: 17142816
    [No Abstract]   [Full Text] [Related]  

  • 46. The human genome project: past, present, and future.
    Watson JD
    Science; 1990 Apr; 248(4951):44-9. PubMed ID: 2181665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Federal stimulus adds momentum to sequencing stampede.
    Fox JL
    Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
    [No Abstract]   [Full Text] [Related]  

  • 48. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
    Mooney KG
    Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opportunities for chemical biologists: a view from the National Institutes of Health.
    Berg JM
    ACS Chem Biol; 2006 Oct; 1(9):547-8. PubMed ID: 17168545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A view from the NIH bridge: perspectives of a program officer.
    Zatz M
    Mol Biol Cell; 2011 Aug; 22(15):2661-3. PubMed ID: 21799136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. US NCI launches nanotechnology plan.
    Alper J
    Nat Biotechnol; 2004 Nov; 22(11):1335-6. PubMed ID: 15529140
    [No Abstract]   [Full Text] [Related]  

  • 52. Flat NIH funding threatens scientific progress.
    J Nucl Med; 2007 May; 48(5):15N, 22N. PubMed ID: 17475944
    [No Abstract]   [Full Text] [Related]  

  • 53. US budget emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
    [No Abstract]   [Full Text] [Related]  

  • 54. DOE announces 20-year science facility plan.
    J Nucl Med; 2004 Jan; 45(1):17N. PubMed ID: 14734663
    [No Abstract]   [Full Text] [Related]  

  • 55. NIH Institutes launch joint venture to map cancer genome.
    Vastag B
    J Natl Cancer Inst; 2006 Feb; 98(3):162. PubMed ID: 16449675
    [No Abstract]   [Full Text] [Related]  

  • 56. Small world, big hopes.
    Watanabe M
    Nat Mater; 2004 Jan; 3(1):73-4. PubMed ID: 14704788
    [No Abstract]   [Full Text] [Related]  

  • 57. Closing the gap.
    Nat Rev Drug Discov; 2006 Feb; 5(2):89. PubMed ID: 16521323
    [No Abstract]   [Full Text] [Related]  

  • 58. US budget yields scant research rises.
    Brumfiel G; Reichhardt T
    Nature; 2005 Nov; 438(7066):264-5. PubMed ID: 16292270
    [No Abstract]   [Full Text] [Related]  

  • 59. Have public-health research funds been diverted in the U.S.?
    Pelley J
    Environ Sci Technol; 2007 Nov; 41(22):7590. PubMed ID: 18075060
    [No Abstract]   [Full Text] [Related]  

  • 60. The HGP: end of phase 1.
    Nat Genet; 2002 Feb; 30(2):125. PubMed ID: 11818951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.